Recruiting soon

CS-001 for Treating Grey Hair

What is being tested

CS-001

+ Placebo Topical Solution

Drug

Who is being recruted

From 30 to 65 Years

+13 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Placebo-ControlledPhase 3

Interventional

Study Start: June 2025

See protocol details

Summary

Principal SponsorApplied Biology, Inc.

Study ContactAndy Goren, MD

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: June 15, 2025

Actual date on which the first participant was enrolled.

This clinical trial is exploring a new treatment called CS-001, which is being studied for its potential to restore color to grey hair. Grey hair occurs when melanin, the pigment that gives hair its color, is not properly stored or transferred in hair follicles. CS-001 is a small molecule that aims to improve this process. Early tests have shown promise in helping hair regain its natural color, making this study important for those looking for effective treatments for grey hair. Participants in this study will receive CS-001 to see if their grey hair can regain its original color. The treatment's safety and effectiveness are carefully monitored throughout the study. Participants will likely apply this treatment directly to their hair, although the exact method is not specified. The study aims to determine whether CS-001 can consistently and safely restore hair color, potentially offering a new solution for those affected by premature greying.

Official TitleClinical Study of CS-001 As a Treatment for Canities (Grey Hair)

NCT06745336

Principal SponsorApplied Biology, Inc.

Study ContactAndy Goren, MD

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

240 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 30 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

5 inclusion criteria required to participate

Age 30 to 65

Diagnosed with Grey Hair (Canities)

Willing and able to apply the treatment as directed, comply with study

Otherwise healthy

Show More Criteria

8 exclusion criteria prevent from participating

A medical history that may interfere with study objectives

Women who are pregnant, lactating, or planning to become pregnant during the study period

Subjects who have experienced a clinically important medical event within 90 days of the visit (e.g., stroke, myocardial infarction, etc)

Subjects who have known allergies to any excipient in CS-001

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental

CS-001 Topical Treatment

Group II

Placebo

Placebo Topical Treatment

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has no location dataSave this study to your profile to know when the location data is available.

Recruiting soonNo study centers